Condensed Consolidated Statements of Equity (Unaudited) - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	[1]	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	[1]	Treasury Stock	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	[1]	Accumulated Other Comprehensive Income (Loss)	Non-controlling Interests
Beginning balance at Dec. 31, 2020	$ 1,579.3	$ (26.2)		$ 0.4	$ 780.8	$ (36.9)		$ (19.3)	$ 808.4	$ 10.7		$ 2.4	$ 6.6
Beginning balance (shares) at Dec. 31, 2020				36,190,000
Increase (Decrease) in Stockholders' Equity
Net income	26.1								25.6				0.5
Other comprehensive income (loss)	(19.2)											(19.2)
Share-based compensation expense	3.4				3.4
Common stock issued from share-based compensation plans	5.6				5.6
Common stock issued from share-based compensation plans (shares)				180,000
Common stock repurchases from share-based compensation plans	(3.0)				(3.0)
Common stock repurchases from share-based compensation plans (in shares)				(20,000.00)
Other	0.0				0.1								(0.1)
Ending balance at Mar. 31, 2021	1,566.0			$ 0.4	750.0			(19.3)	844.7			(16.8)	7.0
Ending balance (shares) at Mar. 31, 2021				36,350,000
Beginning balance at Dec. 31, 2020	1,579.3	$ (26.2)		$ 0.4	780.8	$ (36.9)		(19.3)	808.4	$ 10.7		2.4	6.6
Beginning balance (shares) at Dec. 31, 2020				36,190,000
Increase (Decrease) in Stockholders' Equity
Net income	48.5
Ending balance at Sep. 30, 2021	1,590.5			$ 0.4	755.9			(19.3)	866.1			(20.7)	8.1
Ending balance (shares) at Sep. 30, 2021				36,380,000
Beginning balance at Mar. 31, 2021	1,566.0			$ 0.4	750.0			(19.3)	844.7			(16.8)	7.0
Beginning balance (shares) at Mar. 31, 2021				36,350,000
Increase (Decrease) in Stockholders' Equity
Net income	6.8								6.5				0.3
Other comprehensive income (loss)	7.6											7.6
Share-based compensation expense	2.4				2.4
Common stock issued from share-based compensation plans	0.9				0.9
Common stock issued from share-based compensation plans (shares)				30,000.00
Other	0.1												0.1
Ending balance at Jun. 30, 2021	1,583.8			$ 0.4	753.3			(19.3)	851.2			(9.2)	7.4
Ending balance (shares) at Jun. 30, 2021				36,380,000
Increase (Decrease) in Stockholders' Equity
Net income	15.6								14.9				0.7
Other comprehensive income (loss)	(11.5)											(11.5)
Share-based compensation expense	2.3				2.3
Common stock issued from share-based compensation plans	0.3				0.3
Ending balance at Sep. 30, 2021	1,590.5			$ 0.4	755.9			(19.3)	866.1			(20.7)	8.1
Ending balance (shares) at Sep. 30, 2021				36,380,000
Beginning balance at Dec. 31, 2021	$ 1,625.2			$ 0.4	779.0			(19.3)	878.2			(21.7)	8.6
Beginning balance (shares) at Dec. 31, 2021	36,548,330			36,550,000
Increase (Decrease) in Stockholders' Equity
Net income	$ 10.3								10.2				0.1
Other comprehensive income (loss)	(6.0)											(6.0)
Share-based compensation expense	3.3				3.3
Common stock issued from share-based compensation plans	1.0				1.0
Common stock issued from share-based compensation plans (shares)				80,000.00
Common stock repurchases from share-based compensation plans	(3.2)				(3.2)
Common stock repurchases from share-based compensation plans (in shares)				(20,000.00)
Earthly Labs Inc. purchase price adjustment	(1.2)				(1.2)
Ending balance at Mar. 31, 2022	1,629.4			$ 0.4	778.9			(19.3)	888.4			(27.7)	8.7
Ending balance (shares) at Mar. 31, 2022				36,610,000
Beginning balance at Dec. 31, 2021	$ 1,625.2			$ 0.4	779.0			(19.3)	878.2			(21.7)	8.6
Beginning balance (shares) at Dec. 31, 2021	36,548,330			36,550,000
Increase (Decrease) in Stockholders' Equity
Net income	$ 65.2
Ending balance at Sep. 30, 2022	$ 1,625.9			$ 0.4	784.3			(19.3)	942.6			(90.6)	8.5
Ending balance (shares) at Sep. 30, 2022	36,634,383			36,630,000
Beginning balance at Mar. 31, 2022	$ 1,629.4			$ 0.4	778.9			(19.3)	888.4			(27.7)	8.7
Beginning balance (shares) at Mar. 31, 2022				36,610,000
Increase (Decrease) in Stockholders' Equity
Net income	13.4								13.0				0.4
Other comprehensive income (loss)	(30.9)											(30.9)
Share-based compensation expense	2.3				2.3
Common stock issued from share-based compensation plans	0.4				0.4
Common stock issued from share-based compensation plans (shares)				10,000.00
Common stock repurchases from share-based compensation plans	(0.1)				(0.1)
Other	(0.5)												(0.5)
Ending balance at Jun. 30, 2022	1,614.0			$ 0.4	781.5			(19.3)	901.4			(58.6)	8.6
Ending balance (shares) at Jun. 30, 2022				36,620,000
Increase (Decrease) in Stockholders' Equity
Net income	41.6								41.2				0.4
Other comprehensive income (loss)	(32.5)											(32.0)	(0.5)
Share-based compensation expense	2.3				2.3
Common stock issued from share-based compensation plans	0.5				0.5
Common stock issued from share-based compensation plans (shares)				10,000.00
Common stock repurchases from share-based compensation plans	(0.1)				(0.1)
Other	0.1				0.1
Ending balance at Sep. 30, 2022	$ 1,625.9			$ 0.4	$ 784.3			$ (19.3)	$ 942.6			$ (90.6)	$ 8.5
Ending balance (shares) at Sep. 30, 2022	36,634,383			36,630,000

[1] Refer to Note 2, “Significant Accounting Policies” included in our Annual Report on Form 10-K for the year ended December 31, 2021 for discussion regarding the cumulative effect of change in accounting principle.